| Melasma |
| Uneven skin tone |
| Hyperpigmentation |
| Dark spots and blemishes |
| Post-inflammatory pigmentation |
CREAM
This topical cream is a combination of Hydroquinone, Tretinoin, and Fluocinolone Acetonide formulated for the management of moderate to severe hyperpigmentation disorders such as melasma.
Hydroquinone acts as a depigmenting agent by reducing melanin formation in the skin. Tretinoin promotes skin cell turnover and enhances penetration of Hydroquinone, helping improve skin texture and pigmentation. Fluocinolone Acetonide is a corticosteroid that helps reduce inflammation, redness, and irritation associated with treatment.
| Speciality | Dermatology | Depigmenting Therapy |
|---|---|
| Tags | Skin Lightening | Anti-pigmentation | Dermatology | Skin Care |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.